Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) |
| BNF code | 0302000X0BBAAAA |
| Virtual Medicinal Product | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device |
| Name | Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device |
| Abbreviated name | Atectura Breezhaler 125microg/62.5microg inhalation pdr caps |
| Date of name applicability | 24 Nov 2020 |
| Previous name | Atectura Breezhaler 125micrograms/62.5 micrograms inhalation powder capsules with device |
| Supplier | Sandoz Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Excipients | |
|---|---|
| Ingredient | Lactose |
| Licensed Route | |
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) 30 capsule 3 x 10 capsules | |
dm+d data retrieved from TRUD: release NHSBSA_8.1.0_20220808000001, imported on 8th August 2022 at 04:49:10.